|
US5844092A
(en)
|
1994-03-18 |
1998-12-01 |
Genentech, Inc. |
Human TRK receptors and neurotrophic factor inhibitors
|
|
US5877016A
(en)
|
1994-03-18 |
1999-03-02 |
Genentech, Inc. |
Human trk receptors and neurotrophic factor inhibitors
|
|
KR100823764B1
(ko)
|
2000-06-22 |
2008-04-21 |
제넨테크, 인크. |
아고니스트 안티-티알케이-씨 모노클로날 항체
|
|
US7514446B2
(en)
|
2003-02-20 |
2009-04-07 |
Smithkline Beecham Corporation |
Pyrimidine compounds
|
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
|
PE20060664A1
(es)
|
2004-09-15 |
2006-08-04 |
Novartis Ag |
Amidas biciclicas como inhibidores de cinasa
|
|
DE102005003687A1
(de)
|
2005-01-26 |
2006-07-27 |
Sphingo Tec Gmbh |
Immunoassay zur Bestimmung der Freisetzung von Neurotensin in die Zirkulation
|
|
BRPI0610184A2
(pt)
|
2005-05-16 |
2012-09-25 |
Astrazeneca Ab |
composto, sal farmaceuticamente aceitável de um composto, processo para preparar um composto ou um sal farmaceuticamente aceitável do mesmo, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, métodos para a inibição da atividade de trk, para o tratamento ou profilaxia de cáncer e para a produção de um efeito anti-proliferativo em um animal de sanque quente, e, composição farmacêutica
|
|
ITRM20050290A1
(it)
|
2005-06-07 |
2006-12-08 |
Lay Line Genomics Spa |
Uso di molecole in grado di inibire il legame tra ngf e il suo recettore trka come analgesici ad effetto prolungato.
|
|
PL2395004T3
(pl)
|
2005-06-22 |
2016-08-31 |
Plexxikon Inc |
Pochodne pirolo[2,3-b]pirydyny jako inhibitory kinazy białkowej
|
|
RS53195B2
(sr)
|
2005-08-25 |
2018-08-31 |
Creabilis Therapeutics Spa |
Polimerni konjugati k-252a i njihovi derivati
|
|
WO2007026720A1
(ja)
|
2005-08-31 |
2007-03-08 |
Taisho Pharmaceutical Co., Ltd. |
縮環ピラゾール誘導体
|
|
TWI630207B
(zh)
|
2005-12-13 |
2018-07-21 |
英塞特控股公司 |
作為傑納斯激酶（ＪＡＮＵＳ ＫＩＮＡＳＥ）抑制劑之經雜芳基取代之吡咯并〔２，３-ｂ〕吡啶及吡咯并〔２，３-ｂ〕嘧啶
|
|
KR20090008286A
(ko)
|
2006-03-27 |
2009-01-21 |
네르비아노 메디칼 사이언시스 에스.알.엘. |
키나제 억제제로서의 피리딜- 및 피리미디닐-치환된 피롤-,티오펜- 및 푸란- 유도체
|
|
EA018573B1
(ru)
|
2006-09-22 |
2013-09-30 |
Фармасайкликс, Инк. |
Ингибиторы тирозинкиназы брутона
|
|
PE20081581A1
(es)
|
2006-12-21 |
2008-11-12 |
Plexxikon Inc |
COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA
|
|
WO2008079909A1
(en)
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Pyrrolo [2,3-b] pyridines as kinase modulators
|
|
US7872018B2
(en)
|
2006-12-21 |
2011-01-18 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
EA019524B1
(ru)
|
2007-05-04 |
2014-04-30 |
Айрм Ллк |
СОЕДИНЕНИЯ И КОМПОЗИЦИИ КАК ИНГИБИТОРЫ КИНАЗЫ с-kit И PDGFR
|
|
EP3070090B1
(en)
|
2007-06-13 |
2018-12-12 |
Incyte Holdings Corporation |
Use of salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h- pyrazol-1-yl)-3- cyclopentylpropanenitrile
|
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
|
CN101801962A
(zh)
|
2007-07-09 |
2010-08-11 |
阿斯利康(瑞典)有限公司 |
用于治疗增殖疾病的三取代嘧啶衍生物
|
|
MX2010000617A
(es)
|
2007-07-17 |
2010-05-17 |
Plexxikon Inc |
Compuestos y metodos para modulacion de cinasa, e indicaciones de estos.
|
|
US8293747B2
(en)
|
2007-07-19 |
2012-10-23 |
Merck Sharp & Dohme Corp. |
Heterocyclic amide compounds as protein kinase inhibitors
|
|
EA018503B1
(ru)
|
2007-07-20 |
2013-08-30 |
НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. |
Замещенные производные индазола, активные как ингибиторы киназы
|
|
EA201000603A1
(ru)
|
2007-10-23 |
2010-12-30 |
Новартис Аг |
ПРИМЕНЕНИЕ АНТИТЕЛ К TrkB ДЛЯ ЛЕЧЕНИЯ РЕСПИРАТОРНЫХ НАРУШЕНИЙ
|
|
JP5400791B2
(ja)
|
2007-12-04 |
2014-01-29 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
置換ジヒドロプテリジン−６−オン誘導体、その製造方法及びキナーゼ阻害剤としてのその使用
|
|
CN102015769B
(zh)
|
2008-01-17 |
2014-12-10 |
Irm责任有限公司 |
改进的抗-trkb抗体
|
|
US8207165B2
(en)
|
2008-03-28 |
2012-06-26 |
Nerviano Medical Sciences S.R.L. |
3,4-dihydro-2H-pyrazino[1,2-A]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
PE20091846A1
(es)
|
2008-05-19 |
2009-12-16 |
Plexxikon Inc |
DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
|
|
US8158636B2
(en)
|
2008-05-19 |
2012-04-17 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
MY155535A
(en)
|
2008-05-23 |
2015-10-30 |
Novartis Ag |
Derivatives of quinolines and quinoxalines as protien tyrosine kinase inhibitors
|
|
AU2009257635A1
(en)
|
2008-06-10 |
2009-12-17 |
Plexxikon, Inc. |
5H-Pyrrolo [2,3-b] pyrazine derivatives for kinase modulation, and indications therefor
|
|
SG10201510696RA
(en)
|
2008-06-27 |
2016-01-28 |
Celgene Avilomics Res Inc |
Heteroaryl compounds and uses thereof
|
|
ES2532732T3
(es)
|
2008-07-29 |
2015-03-31 |
Nerviano Medical Sciences S.R.L. |
Uso de un inhibidor de CDK para el tratamiento del glioma
|
|
EP2376492B1
(en)
|
2008-09-19 |
2015-04-08 |
Nerviano Medical Sciences S.r.l. |
3,4 DIHYDRO-2H-PYRROLO[1,2-a]PYRAZIN-1-ONE DERIVATIVES
|
|
DK2350075T3
(da)
|
2008-09-22 |
2014-05-26 |
Array Biopharma Inc |
Substituerede imidazo[1,2b]pyridazinforbindelser som trk-kinase-inhibitorer
|
|
PT3106463T
(pt)
|
2008-10-22 |
2018-05-18 |
Array Biopharma Inc |
Compostos de pirazolo[1,5-]pirimidina substituídos como inibidores de cinase trk
|
|
CN102223885B
(zh)
|
2008-11-24 |
2013-04-03 |
内尔维阿诺医学科学有限公司 |
用于治疗间皮瘤的cdk抑制剂
|
|
JO3265B1
(ar)
|
2008-12-09 |
2018-09-16 |
Novartis Ag |
مثبطات بيريديلوكسى اندولات vegf-r2 واستخدامها لعلاج المرض
|
|
TWI665200B
(zh)
|
2009-01-15 |
2019-07-11 |
英塞特公司 |
製造ｊａｋ抑制劑之方法及相關中間化合物
|
|
WO2010111527A1
(en)
|
2009-03-26 |
2010-09-30 |
Plexxikon, Inc. |
Pyrazolo [ 3, 4 -b] pyridines as kinase inhibitors and their medical use
|
|
EP3643312A1
(en)
|
2009-05-22 |
2020-04-29 |
Incyte Holdings Corporation |
3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
|
|
JP5789602B2
(ja)
|
2009-06-15 |
2015-10-07 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
置換ピリミジニルピロロピリジノン誘導体、これらの製造のための方法およびキナーゼ阻害剤としてのこれらの使用
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
CN105541847B
(zh)
|
2009-10-09 |
2019-08-16 |
因西特控股公司 |
3-(4-(7H-吡咯并[2,3-d]嘧啶-4-基)-1H-吡唑-1-基)-3-环戊基丙腈的羟基衍生物、酮基衍生物和葡糖苷酸衍生物
|
|
JP5883395B2
(ja)
|
2010-01-29 |
2016-03-15 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
タンパク質キナーゼモジュレーターとしての６，７−ジヒドロイミダゾ［１，５−ａ］ピラジン−８（５ｈ）−オン誘導体
|
|
TWI619713B
(zh)
|
2010-04-21 |
2018-04-01 |
普雷辛肯公司 |
用於激酶調節的化合物和方法及其適應症
|
|
RU2735545C2
(ru)
|
2010-05-20 |
2020-11-03 |
Эррэй Биофарма Инк. |
Макроциклические соединения в качестве ингибиторов киназы trk
|
|
UY33597A
(es)
|
2010-09-09 |
2012-04-30 |
Irm Llc |
Compuestos y composiciones como inhibidores de la trk
|
|
WO2012034095A1
(en)
|
2010-09-09 |
2012-03-15 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
|
CN103339134B
(zh)
|
2011-01-26 |
2015-12-23 |
内尔维阿诺医学科学有限公司 |
三环吡咯并衍生物、它们的制备方法和它们作为激酶抑制剂的应用
|
|
EP2668188B1
(en)
|
2011-01-26 |
2016-05-18 |
Nerviano Medical Sciences S.r.l. |
Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
|
|
PL2672967T3
(pl)
|
2011-02-07 |
2019-04-30 |
Plexxikon Inc |
Związki i sposoby modulacji kinaz i wskazania ku temu
|
|
CN103403002B
(zh)
|
2011-02-24 |
2016-06-22 |
内尔维阿诺医学科学有限公司 |
作为激酶抑制剂的噻唑基苯基-苯磺酰氨基衍生物
|
|
KR20140014184A
(ko)
|
2011-02-25 |
2014-02-05 |
아이알엠 엘엘씨 |
Trk 억제제로서의 화합물 및 조성물
|
|
EP2702055A1
(en)
|
2011-04-11 |
2014-03-05 |
Nerviano Medical Sciences S.r.l. |
Pyrazolyl-pyrimidine derivatives as kinase inhibitors
|
|
RU2621732C2
(ru)
|
2011-04-19 |
2017-06-07 |
НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. |
Замещенные пиримидинилпирролы, активные в качестве ингибиторов киназы
|
|
DK2707359T3
(en)
|
2011-05-12 |
2017-01-23 |
Nerviano Medical Sciences Srl |
SUBSTITUTED INDAZOLD DERIVATIVES ACTIVE AS KINase INHIBITORS
|
|
MY173181A
(en)
|
2011-05-13 |
2020-01-02 |
Array Biopharma Inc |
Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
|
|
EP2736514B1
(en)
|
2011-07-28 |
2017-10-18 |
Nerviano Medical Sciences S.r.l. |
Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors
|
|
WO2013050448A1
(en)
|
2011-10-07 |
2013-04-11 |
Nerviano Medical Sciences S.R.L. |
4-ALKYL SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASES INHIBITORS
|
|
US9145418B2
(en)
|
2011-10-07 |
2015-09-29 |
Nerviano Medical Sciences S.R.L. |
Substituted 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-ones as protein kinase inhibitors
|
|
EP2779833A4
(en)
|
2011-11-14 |
2015-03-18 |
Tesaro Inc |
MODULATION OF SPECIFIC TYROSINE KINASES
|
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
|
US9242976B2
(en)
|
2012-01-13 |
2016-01-26 |
Bristol-Myers Squibb Company |
Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
|
|
WO2013116339A1
(en)
*
|
2012-01-31 |
2013-08-08 |
Vertex Pharmaceuticals Incorporated |
High potency formulations of vx-950
|
|
EP2842955B1
(en)
|
2012-04-26 |
2016-10-05 |
ONO Pharmaceutical Co., Ltd. |
Trk-inhibiting compound
|
|
JP6231556B2
(ja)
|
2012-05-23 |
2017-11-15 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
Ｎ−［５−（３，５−ジフルオロ−ベンジル）−１ｈ−インダゾール−３−イル］−４−（４−メチル−ピペラジン−１−イル）−２−（テトラヒドロ−ピラン−４−イルアミノ）−ベンズアミドの調製方法
|
|
TWI585088B
(zh)
|
2012-06-04 |
2017-06-01 |
第一三共股份有限公司 |
作爲激酶抑制劑之咪唑并［１，２－ｂ］嗒衍生物
|
|
AR091273A1
(es)
|
2012-06-08 |
2015-01-21 |
Biogen Idec Inc |
Inhibidores de pirimidinil tirosina quinasa
|
|
US9611267B2
(en)
|
2012-06-13 |
2017-04-04 |
Incyte Holdings Corporation |
Substituted tricyclic compounds as FGFR inhibitors
|
|
EP2872144A4
(en)
|
2012-07-11 |
2015-12-02 |
Nimbus Iris Inc |
IRAQ INHIBITOR AND USES THEREOF
|
|
DK2872491T3
(da)
|
2012-07-11 |
2021-08-09 |
Blueprint Medicines Corp |
Inhibitorer af fibroblastvækstfaktorreceptoren
|
|
WO2014019908A2
(en)
|
2012-08-02 |
2014-02-06 |
Nerviano Medical Sciences S.R.L. |
Substituted pyrroles active as kinases inhibitors
|
|
AU2013312296B2
(en)
|
2012-09-10 |
2017-06-22 |
Principia Biopharma Inc. |
Pyrazolopyrimidine compounds as kinase inhibitors
|
|
EP2903972B1
(en)
|
2012-10-04 |
2019-12-04 |
University of Utah Research Foundation |
Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
|
|
US9604980B2
(en)
|
2012-11-07 |
2017-03-28 |
Nerviano Medical Sciences S.R.L. |
Substituted pyrimidinyl and pyridinyl-pyrrolopyridinones, process for their preparation and their use as kinase inhibitors
|
|
EA029706B1
(ru)
|
2012-11-12 |
2018-05-31 |
Игнайта, Инк. |
Сложные алкиловые эфиры бендамустина и способы их применения
|
|
EP2922844B1
(en)
|
2012-11-13 |
2018-01-10 |
Array Biopharma, Inc. |
N-pyrrolidinyl, n'-pyrazolyl- urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
WO2014078378A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
US9981959B2
(en)
|
2012-11-13 |
2018-05-29 |
Array Biopharma Inc. |
Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
WO2014078325A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(monocyclic aryl),n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
US9822118B2
(en)
|
2012-11-13 |
2017-11-21 |
Array Biopharma Inc. |
Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
US9790178B2
(en)
|
2012-11-13 |
2017-10-17 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
US9809578B2
(en)
|
2012-11-13 |
2017-11-07 |
Array Biopharma Inc. |
Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trkA kinase inhibitors
|
|
WO2014078331A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(arylalkyl)-n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
EP2920166B1
(en)
|
2012-11-13 |
2016-11-02 |
Array Biopharma, Inc. |
Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain
|
|
WO2014078328A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-bicyclic aryl,n'-pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
CN103848810A
(zh)
|
2012-11-30 |
2014-06-11 |
北京赛林泰医药技术有限公司 |
鲁顿酪氨酸激酶抑制剂
|
|
HUE042591T2
(hu)
|
2013-02-19 |
2019-07-29 |
Ono Pharmaceutical Co |
TRK-gátló vegyület
|
|
WO2014160521A1
(en)
|
2013-03-15 |
2014-10-02 |
Blueprint Medicines Corporation |
Piperazine derivatives and their use as kit modulators
|
|
WO2014143672A1
(en)
|
2013-03-15 |
2014-09-18 |
Biogen Idec Ma Inc. |
Macrocyclic compounds as irak4 inhibitors for the treatment of inflammatory diseases
|
|
JP6397897B2
(ja)
|
2013-05-14 |
2018-09-26 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
ピロロ［２，３−ｄ］ピリミジン誘導体、その製造方法及びキナーゼ阻害剤としてのその使用
|
|
KR20160013028A
(ko)
|
2013-05-30 |
2016-02-03 |
플렉시콘, 인코퍼레이티드 |
키나제 조정을 위한 화합물 및 그에 대한 적응증
|
|
UY35625A
(es)
|
2013-06-25 |
2014-12-31 |
Bristol Myers Squibb Company Una Corporación Del Estado De Delaware |
Compuestos de tetrahidrocarbazol y carbazol carboxamida sustituidos como inhibidores de quinasa
|
|
JP6458018B2
(ja)
|
2013-07-02 |
2019-01-23 |
ファーマサイクリックス エルエルシー |
キナーゼ阻害剤としてのプリノン化合物
|
|
WO2015017533A1
(en)
|
2013-07-30 |
2015-02-05 |
Blueprint Medicines Corporation |
Ntrk2 fusions
|
|
US10875930B2
(en)
|
2013-07-30 |
2020-12-29 |
Blueprint Medicines Corporation |
PIK3C2G fusions
|
|
PT3049417T
(pt)
|
2013-07-31 |
2019-01-24 |
Merck Patent Gmbh |
Piridinas, pirimidinas e pirazinas, como inibidores de btk e utilizações das mesmas
|
|
US9840517B2
(en)
|
2013-09-18 |
2017-12-12 |
Beijing Hanmi Pharmaceutical Co., Ltd. |
Compound inhibiting activities of BTK and/or JAK3 kinases
|
|
CN104341388B
(zh)
|
2013-10-16 |
2017-03-22 |
北京诺诚健华医药科技有限公司 |
芳香族酰胺类衍生物、其制备方法及其在医药上的应用
|
|
PT3409674T
(pt)
|
2013-10-17 |
2022-07-18 |
Blueprint Medicines Corp |
Processo para preparar composições úteis para tratar distúrbios relacionados com kit
|
|
US9334263B2
(en)
|
2013-10-17 |
2016-05-10 |
Blueprint Medicines Corporation |
Compositions useful for treating disorders related to kit
|
|
BR112016008849B8
(pt)
|
2013-10-25 |
2022-09-06 |
Blueprint Medicines Corp |
Compostos ou sais farmaceuticamente aceitáveis dos mesmos, uso dos referidos compostos e composições farmacêuticas
|
|
WO2015061752A1
(en)
*
|
2013-10-25 |
2015-04-30 |
Pharmacyclics, Inc. |
Treatment using bruton's tyrosine kinase inhibitors and immunotherapy
|
|
EP3066094B1
(en)
|
2013-11-08 |
2020-01-08 |
Takeda Pharmaceutical Company Limited |
Pyrazole for the treatment autoimmune disorders
|
|
JP6345786B2
(ja)
|
2013-12-05 |
2018-06-20 |
ファーマサイクリックス エルエルシー |
ブルトン型チロシンキナーゼの阻害剤
|
|
SG11201604595VA
(en)
|
2013-12-11 |
2016-07-28 |
Biogen Ma Inc |
Biaryl compounds useful for the treatment of human diseases in oncology, neurology and immunology
|
|
US9908872B2
(en)
|
2013-12-13 |
2018-03-06 |
Dana-Farber Cancer Institute, Inc. |
Methods to treat lymphoplasmacytic lymphoma
|
|
JP6879740B2
(ja)
|
2013-12-13 |
2021-06-02 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
リンパ形質細胞性リンパ腫を処置する方法
|
|
PT3466955T
(pt)
|
2014-01-13 |
2021-01-29 |
Aurigene Discovery Tech Ltd |
Método de preparação de derivados de oxazolo[4,5-b] piridina e tiazolo[4,5-b] piridina como inibidores de irak-4 para o tratamento do cancro
|
|
US9695165B2
(en)
|
2014-01-15 |
2017-07-04 |
Blueprint Medicines Corporation |
Inhibitors of the fibroblast growth factor receptor
|
|
HRP20191283T1
(hr)
|
2014-01-24 |
2019-10-18 |
Turning Point Therapeutics, Inc. |
Diaril makrocikli kao modulatori protein kinaze
|
|
TWI672141B
(zh)
|
2014-02-20 |
2019-09-21 |
美商醫科泰生技 |
投予ｒｏｓ１突變癌細胞之分子
|
|
EP3132056B1
(en)
|
2014-04-18 |
2021-11-24 |
Blueprint Medicines Corporation |
Pik3ca fusions
|
|
US20170044621A1
(en)
|
2014-04-18 |
2017-02-16 |
Blueprint Medicines Corporation |
Met fusions
|
|
LT3154959T
(lt)
|
2014-05-15 |
2019-09-25 |
Array Biopharma, Inc. |
1-((3s,4r)-4-(3-fluorfenil)-1-(2-metoksietil)pirolidin-3-il)-3-(4-metil-3-(2-metilpirimidin-5-il)-1-fenil-1h-pirazol-5-il)karbamidas kaip trka kinazės inhibitorius
|
|
EP3155131B1
(en)
|
2014-06-10 |
2020-02-12 |
Blueprint Medicines Corporation |
Raf1 fusions
|
|
US10246750B2
(en)
|
2014-06-10 |
2019-04-02 |
Blueprint Medicines Corporation |
Method for detection of a TECR:PKN1 or an ANXA4:PKN1 gene fusion
|
|
WO2015193740A2
(en)
|
2014-06-17 |
2015-12-23 |
Acerta Pharma B.V. |
Therapeutic combinations of a btk inhibitor, a pi3k inhibitor and/or a jak-2 inhibitor
|
|
EP3169809B1
(en)
|
2014-07-17 |
2020-04-29 |
Blueprint Medicines Corporation |
Prkc fusions
|
|
US10370723B2
(en)
|
2014-07-17 |
2019-08-06 |
Blueprint Medicines Corporation |
TERT fusions
|
|
EP3169804B3
(en)
|
2014-07-17 |
2019-09-18 |
Blueprint Medicines Corporation |
Fgr fusions
|
|
WO2016022569A1
(en)
|
2014-08-04 |
2016-02-11 |
Blueprint Medicines Corporation |
Compositions useful for treating disorders related to kit
|
|
JP2017523206A
(ja)
*
|
2014-08-07 |
2017-08-17 |
ファーマサイクリックス エルエルシー |
ブルトン型チロシンキナーゼ阻害剤の新規製剤
|
|
BR122017020365A2
(pt)
|
2014-08-18 |
2019-09-10 |
Ono Pharmaceutical Co |
sal de adição de ácido do composto inibidor de trk
|
|
WO2016053771A1
(en)
|
2014-09-30 |
2016-04-07 |
Merck Sharp & Dohme Corp. |
Inhibitors of irak4 activity
|
|
CN106922146B
(zh)
|
2014-10-02 |
2020-05-26 |
豪夫迈·罗氏有限公司 |
用于治疗由布鲁顿酪氨酸激酶(btk)介导的疾病的吡唑甲酰胺化合物
|
|
PT3461821T
(pt)
|
2014-10-24 |
2020-08-05 |
Bristol Myers Squibb Co |
Compostos de indol carboxamida úteis como inibidores de quinase
|
|
CA2965516A1
(en)
|
2014-10-24 |
2016-04-28 |
Bristol-Myers Squibb Company |
Tricyclic atropisomer compounds
|
|
CA2967125C
(en)
|
2014-11-14 |
2022-10-25 |
Nerviano Medical Sciences S.R.L. |
6-amino-7-bicyclo-7-deaza-purine derivatives as protein kinase inhibitors
|
|
EP3218380B1
(en)
|
2014-11-16 |
2021-03-17 |
Array Biopharma, Inc. |
Preparation of a crystalline form of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate
|
|
US20170356052A1
(en)
|
2014-11-18 |
2017-12-14 |
Blueprint Medicines Corporation |
Prkacb fusions
|
|
WO2016106628A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
|
KR20170109546A
(ko)
|
2015-02-05 |
2017-09-29 |
메르크 파텐트 게엠베하 |
Irak1/4 억제제로서의 매크로시클릭 화합물 및 이들의 용도
|
|
US9717745B2
(en)
|
2015-03-19 |
2017-08-01 |
Zhejiang DTRM Biopharma Co. Ltd. |
Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases
|
|
WO2016161570A1
(en)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
Azacarbazole btk inhibitors
|
|
WO2016161571A1
(en)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
Indazole and azaindazole btk inhibitors
|
|
SG11201707752SA
(en)
|
2015-04-22 |
2017-11-29 |
Rigel Pharmaceuticals Inc |
Pyrazole compounds and method for making and using the compounds
|
|
TW201701879A
(zh)
|
2015-04-30 |
2017-01-16 |
拜耳製藥公司 |
Ｉｒａｋ４抑制劑組合
|
|
US20180179210A1
(en)
|
2015-05-27 |
2018-06-28 |
Pharmascience Inc. |
Inhibitors of the TEC Kinase Enzyme Family
|
|
EP4112618A1
(en)
|
2015-06-03 |
2023-01-04 |
Principia Biopharma Inc. |
Tyrosine kinase inhibitors
|
|
WO2017049069A1
(en)
|
2015-09-18 |
2017-03-23 |
Merck Patent Gmbh |
Heteroaryl compounds as irak inhibitors and uses thereof
|
|
US20170035881A1
(en)
|
2015-10-19 |
2017-02-09 |
Acerta Pharma B.V. |
Therapeutic Combinations of an IRAK4 Inhibitor and a BTK Inhibitor
|
|
CN108368086B
(zh)
|
2015-12-16 |
2021-01-08 |
勃林格殷格翰国际有限公司 |
可用于治疗自身免疫疾病的二吡唑基衍生物
|
|
UA127863C2
(uk)
*
|
2015-12-16 |
2024-01-31 |
Локсо Онколоджі, Інк. |
Сполуки, які можна застосовувати як інгібітори кінази
|
|
WO2017103661A1
(en)
|
2015-12-18 |
2017-06-22 |
Edel-For-Life Sa |
Quality control assay to monitor the completeness of pathogen or targeted cell inactivation treatments in biological, foodstuff, drinks and cosmetics products
|
|
WO2017134685A2
(en)
|
2016-02-02 |
2017-08-10 |
Sun Pharma Advanced Research Company Limited |
Novel hydrazino compounds as btk inhibitors
|
|
WO2017205769A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
|
TW201815799A
(zh)
|
2016-07-28 |
2018-05-01 |
美商Ｔｐ生物醫藥公司 |
巨環激酶抑制劑
|
|
CA3158951A1
(en)
|
2016-08-15 |
2018-02-22 |
Purdue Research Foundation |
4-substituted aminoisoquinoline derivatives
|
|
AU2017312970B2
(en)
|
2016-08-16 |
2021-08-12 |
Merck Patent Gmbh |
2-oxo-imidazopyridines as reversible BTK inhibitors and uses thereof
|
|
CA2939286A1
(en)
|
2016-08-17 |
2018-02-17 |
Pharmascience Inc. |
Spirocyclic containing compounds and pharmaceutical uses thereof
|
|
SG11201901197PA
(en)
|
2016-08-24 |
2019-03-28 |
Arqule Inc |
Amino-pyrrolopyrimidinone compounds and methods of use thereof
|
|
MA46205A
(fr)
|
2016-09-08 |
2019-07-17 |
Sabila Biosciences Llc |
Composés 1,2-dithiolane utiles dans la neuroprotection, les maladies et les états auto-immuns et cancéreux
|
|
KR102686957B1
(ko)
|
2016-11-08 |
2024-07-22 |
주식회사 대웅제약 |
신규한 피롤로피리미딘 유도체 및 이를 포함하는 약학적 조성물
|
|
JOP20190113A1
(ar)
|
2016-11-18 |
2019-05-15 |
Biocad Joint Stock Co |
مثبطات بروتون تيروزين كيناز
|
|
CN108101905A
(zh)
|
2016-11-24 |
2018-06-01 |
中国科学院上海药物研究所 |
嘧啶并[5,4-b]吲嗪或嘧啶并[5,4-b]吡呤化合物、其制备方法及用途
|
|
WO2018103060A1
(en)
|
2016-12-09 |
2018-06-14 |
Janssen Pharmaceutica Nv |
Inhibitors of bruton's tyrosine kinase and methods of their use
|
|
CN106831789A
(zh)
|
2016-12-21 |
2017-06-13 |
南京亘泰医药技术有限公司 |
布鲁顿酪氨酸激酶抑制剂
|
|
UY37559A
(es)
|
2017-01-06 |
2018-05-31 |
Pharmacyclics Llc |
Pirazolo[3,4-b]piridina y pirrolo[2,3-b]piridina como inhibidores de la tirosina quinasa de bruton
|
|
CN118021814A
(zh)
|
2017-04-21 |
2024-05-14 |
Epizyme股份有限公司 |
用ehmt2抑制剂进行的组合疗法
|
|
MX2022006631A
(es)
|
2019-12-06 |
2022-09-07 |
Loxo Oncology Inc |
Dosificacion de un inhibidor de la tirosina cinasa de bruton.
|
|
TWI809489B
(zh)
|
2020-09-10 |
2023-07-21 |
美商絡速藥業公司 |
用於製備(s)-5-胺基-3-(4-((5-氟-2-甲氧基苯甲醯胺基)甲基)苯基)-1-(1,1,1-三氟丙烷-2-基)-1h-吡唑-4-甲醯胺之方法及中間體
|